{"transactions":[{"id":739388,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T17:23:27.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.74,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-26-073589","document":"tm2617745-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465926073589/tm2617745-7_4seq1.xml","form_type":"4"}},{"id":739387,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T17:23:27.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 10, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":100464,"source":{"system":"sec-edgar","filing":"0001104659-26-073589","document":"tm2617745-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465926073589/tm2617745-7_4seq1.xml","form_type":"4"}},{"id":1111194,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T16:23:07.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":44000,"derivative":{"exercise_price":8.82,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-25-059382","document":"tm2517945-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465925059382/tm2517945-2_4seq1.xml","form_type":"4"}},{"id":1111193,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T16:23:07.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 11, 2025, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":86464,"source":{"system":"sec-edgar","filing":"0001104659-25-059382","document":"tm2517945-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465925059382/tm2517945-2_4seq1.xml","form_type":"4"}},{"id":1447961,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-26T18:39:29.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":36000,"derivative":{"exercise_price":7.91,"expiration_date":"2034-07-23","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-24-083097","document":"tm2420266-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465924083097/tm2420266-2_4seq1.xml","form_type":"4"}},{"id":1447960,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-26T18:39:29.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 24, 2024, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":72464,"source":{"system":"sec-edgar","filing":"0001104659-24-083097","document":"tm2420266-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465924083097/tm2420266-2_4seq1.xml","form_type":"4"}},{"id":1851658,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T19:09:32.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":36000,"derivative":{"exercise_price":5.31,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-23-072408","document":"tm2318782-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465923072408/tm2318782-6_4seq1.xml","form_type":"4"}},{"id":1851657,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T19:09:32.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 14, 2023, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":60464,"source":{"system":"sec-edgar","filing":"0001104659-23-072408","document":"tm2318782-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465923072408/tm2318782-6_4seq1.xml","form_type":"4"}},{"id":2225068,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T20:08:29.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":26800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":26800,"derivative":{"exercise_price":3.43,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":26800},"source":{"system":"sec-edgar","filing":"0001104659-22-073149","document":"tm2218958-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465922073149/tm2218958-4_4seq1.xml","form_type":"4"}},{"id":2225067,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T20:08:29.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":8933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 16, 2022, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Company\"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date."}],"balance_after":48464,"source":{"system":"sec-edgar","filing":"0001104659-22-073149","document":"tm2218958-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465922073149/tm2218958-4_4seq1.xml","form_type":"4"}},{"id":2658502,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T20:03:35.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":13.51,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-21-084301","document":"tm2120338-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465921084301/tm2120338-5_4seq1.xml","form_type":"4"}},{"id":2853752,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T16:31:49.000Z","date":"2021-02-15","kind":"other","acquired":false,"shares":8604,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund III, L.P. (\"Versant Side Fund\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Shares held by Versant Side Fund. Versant Ventures III GP is the general partner of Versant Side Fund. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-006897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924321006897/doc4.xml","form_type":"4"}},{"id":2853751,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T16:31:49.000Z","date":"2021-02-15","kind":"other","acquired":true,"shares":35912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Venture III GP."}],"balance_after":39531,"source":{"system":"sec-edgar","filing":"0000899243-21-006897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924321006897/doc4.xml","form_type":"4"}},{"id":2853750,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T16:31:49.000Z","date":"2021-02-15","kind":"other","acquired":false,"shares":375121,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures III GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures III GP. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures III GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-006897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924321006897/doc4.xml","form_type":"4"}},{"id":2853749,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T16:31:49.000Z","date":"2021-02-15","kind":"other","acquired":true,"shares":375121,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures III GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures III GP. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures III GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein."}],"balance_after":375121,"source":{"system":"sec-edgar","filing":"0000899243-21-006897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924321006897/doc4.xml","form_type":"4"}},{"id":2853748,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T16:31:49.000Z","date":"2021-02-15","kind":"other","acquired":false,"shares":1456780,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital III, L.P. (\"Versant III\"), to its partners, pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant III. Versant Ventures III, LLC (\"Versant Ventures III GP\") is the general partner of Versant III. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant III; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-006897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924321006897/doc4.xml","form_type":"4"}},{"id":2953137,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-08T18:14:23.000Z","date":"2020-12-04","kind":"other","acquired":false,"shares":4403,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund III, L.P. (\"Versant Side Fund\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Shares held by Versant Side Fund. Versant Ventures III GP is the general partner of Versant Side Fund. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant Side Fund; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein."}],"balance_after":8604,"source":{"system":"sec-edgar","filing":"0000899243-20-033030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924320033030/doc4.xml","form_type":"4"}},{"id":2953136,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-08T18:14:23.000Z","date":"2020-12-04","kind":"other","acquired":true,"shares":3619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Venture III GP."}],"balance_after":3619,"source":{"system":"sec-edgar","filing":"0000899243-20-033030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924320033030/doc4.xml","form_type":"4"}},{"id":2953135,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-08T18:14:23.000Z","date":"2020-12-04","kind":"other","acquired":false,"shares":37208,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures III GP to its members."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures III GP. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures III GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-20-033030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924320033030/doc4.xml","form_type":"4"}},{"id":2953134,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-08T18:14:23.000Z","date":"2020-12-04","kind":"other","acquired":true,"shares":37208,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a change in the form of ownership of Versant Ventures III GP by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant III."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by Versant Ventures III GP. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant Ventures III GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein."}],"balance_after":37208,"source":{"system":"sec-edgar","filing":"0000899243-20-033030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924320033030/doc4.xml","form_type":"4"}},{"id":2953133,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-08T18:14:23.000Z","date":"2020-12-04","kind":"other","acquired":false,"shares":745597,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital III, L.P. (\"Versant III\") to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Versant III. Versant Ventures III, LLC (\"Versant Ventures III GP\") is the general partner of Versant III. The Reporting Person is a managing member of Versant Ventures III GP and may be deemed to share voting and dispositive power over the shares held by Versant III; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein."}],"balance_after":1456780,"source":{"system":"sec-edgar","filing":"0000899243-20-033030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000089924320033030/doc4.xml","form_type":"4"}},{"id":3098392,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T16:03:38.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":8.75,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-20-077444","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465920077444/a4.xml","form_type":"4"}},{"id":3490992,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T17:20:02.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":3.9,"expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-19-035413","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465919035413/a4.xml","form_type":"4"}},{"id":3892173,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T17:23:19.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":18000,"derivative":{"exercise_price":8.14,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-18-040495","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465918040495/a4.xml","form_type":"4"}},{"id":4297789,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":38615,"kind":"person","name":"Warden Charles M","position":1,"cik":"0001354802","reported_name":"Warden Charles M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-01T18:30:36.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 100% of the securities on the first anniversary of the grant date."}],"balance_after":13500,"derivative":{"exercise_price":10.71,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-17-037013","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1354802/000110465917037013/a4.xml","form_type":"4"}}]}